The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas

Pituitary

Volumn 14, Issue 3, 2011, Pages 266-275

  Qiu, Lubin ^a   He, Dongsheng ^a   Fan, Xiang ^c   Li, Zhi ^a   Liao, Chuangxin ^a   Zhu, Yonghong ^b   Wang, Haijun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c THE FIFTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

IL 17; IL 17R; MMP 9; Pituitary adenomas

Indexed keywords

GELATINASE B; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR;

ADULT; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; INTERLEUKIN 17 BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-17; MAGNETIC RESONANCE IMAGING; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PITUITARY NEOPLASMS; RECEPTORS, INTERLEUKIN-17; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 80053918838     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-011-0292-5     Document Type: Article

References (49)

1. Numasaki M, Fukushi J, Ono M, Narula SK, Zavodny PJ, Kudo T, Robbins PD, Tahara H, Lotze MT (2003) Interleukin-17 promotes angiogenesis and tumor growth. Blood 101:2620-2627 (Pubitemid 36857622)
2. Pongcharoen S, Niumsup P, Sanguansermsri D, Supalap K, Butkhamchot P (2006) The effect of interleukin-17 on the proliferation and invasion of JEG-3 human choriocarcinoma cells. Am J Reprod Immunol 55:291-300 (Pubitemid 43349265)
3. Moseley TA, Haudenschild DR, Rose L, Reddi AH (2003) Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 14:155-174 (Pubitemid 36389528)
4. Ge D, You Z (2008) Expression of interleukin-17RC protein in normal human tissues. Int Archi Med 1:19
5. Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neuro-surg Oct 33(4):610-617 discussion 617618
6. Cottier J-P, Destrieux C, Brunereau L, Bertrand P, Moreau L, Jan M, Herbreteau D (2000) Cavernous sinus invasion by pituitary adenoma: MR imaging. Radiology 215:463-469 (Pubitemid 30237846)
7. Vieira JO Jr, Cukiert A, Liberman B (2006) Evaluation of magnetic resonance imaging criteria for cavernous sinus invasion in patients with pituitary adenomas: logistic regression analysis and correlation with surgical findings. Surg Neurol 65:130-135 (Pubitemid 43112145)
8. Goel A, Nadkarni T, Muzumdar D, Desai K, Phalke U, Sharma P (2004) Giant pituitary tumors: a study based on surgical treatment of 118 cases. Surg Neurol 61:436-446
9. Nakashiro K, Hayashi Y, Oyasu R (2003) Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue. Oncol Rep 10: 1149-1153
10. Xie L-Q, Bian L-J, Li Z (2010) Co-elevated expression of hepatocyte growth factor and interleukin-8 contributes to poor prognosis of patients with primary nasopharyngeal carcinoma. Oncol Rep 23:141-150
11. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539-545 (Pubitemid 32173595)
12. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860-867 (Pubitemid 36019639)
13. O'Sullivan C, Lewis CE, Harris AL, McGee JO (1993) Secretion of epidermal growth factor by macrophages associated with breast carcinoma. Lancet 342:148-149 (Pubitemid 23200443)
14. Pusztai L, Clover LM, Cooper K, Starkey PM, Lewis CE, McGee JO (1994) Expression of tumour necrosis factor alpha and its receptors in carcinoma of the breast. Br J Cancer 70:289-292 (Pubitemid 24247151)
15. Shaoguang W, Rhee K-J, Albesiano E, Rabizadeh S, Xinqun W, Yen H-R, Huso DL, Brancati FL, Wick E, McAllister F, Housseau F, Pardoll DM, Sears CL (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15(9):1016-1022
16. Kramer JM, Gaffen SL (2007) Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. J Periodontol 78: 1083-1093
17. Xiao M, Wang C, Zhang J, Li Z, Zhao X, Qin Z (2009) IFNγ promotes papilloma development by up-regulating Th17-associ-ated inflammation. Cancer Res 69(5):2010-2017
18. Blavier L, Lazaryev A, Dorey F, Shackleford GM, DeClerck YA (2006) Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis. Cancer Res 66:2691-2699
19. Kawamoto H, Uozumi T, Kamamtot K, Arita K, Yano T, Hirohata T (1996) Type IV collagenase activity and cavenous sinus invasion in human pituitary adenomas. Acta Neurochir (Wien) 138:390-395 (Pubitemid 26125013)
20. Hussaini IM, Trotter C, Zhao Y, Abdel-Fattah R, Amos S, Xiao A, Agi CU, Redpath GT, Fang Z, Leung GKK, Lopes MBS, Laws ER Jr (2007) Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line. Am J Pathol 170:356-365 (Pubitemid 47339213)
21. Gong J, Zhao Y, Abdel-Fattah R, Amos S, Xiao A, Lopes MBS, Hussaini IM, Laws ER (2008) Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas. Pituitary 11:37-48 (Pubitemid 351168083)
22. Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC (1998) Matrix metalloproteinase expression increases after cerebral focal ischemia in rats. Strock 29:1020-1030
23. Turner HE, Nagy Z, Esiri MM, Harris AL, Wass JA (2000) Role of matrix metalloproteinase -9 in pituitary tumor behavior. J Clin Endocorinol Metab 85:2931-2935 (Pubitemid 32269176)
24. Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M, Mineau F, Pelletier JP (1998) IL-17 stimulates the production and expression of proinflammatory cytokines, IL-β and TNF-α, by human macrophages. J Immunol 160:3513-3521 (Pubitemid 28164746)
25. Jovanovic DV, Martel-Pelletier J, Di Battista JA, Mineau F, Jolicoeur FC, Benderdour M, Pelletier JP (2000) Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis. Arthritis Rheum 43:1134-1144 (Pubitemid 30368194)
26. Moseley TA, Haudenschild DR, Rose L, Reddi AH (2003) Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 14(2):155-174 (Pubitemid 36389528)
27. Yao Z, Fanslow WC, Seldin MF, Rousseau AM, Painter SL, Comeau MR, Cohen JI, Spriggs MK (1995) Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3(6):811-821 (Pubitemid 26091152)
28. Gaffen SL (2009) Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 9:556-567
29. Spriggs MK (1997) Interleukin-17 and its receptor. J Clin Immunol 17(5):366-369 (Pubitemid 27431975)
30. Ge D, You Z (2008) Expression of interleukin-17RC protein in normal human tissues. Int Archi Medicine 1:19
31. Koenders MI, Kolls JK, Oppers-Walgreen B, van den Bersselaar L, Joosten LA, Schurr JR, Schwarzenberger P, van den Berg WB, Lubberts E (2005) Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. Arthritis Rheum 52:3239-3247 (Pubitemid 41447107)
32. Honorati MC, Cattini L, Facchini A (2007) Possible prognostic role of IL-17R in osteosarcoma. J Cancer Res Clin Oncol 133: 1017-1021 (Pubitemid 47561720)
33. H17 lineage. Nature 441:231-234
34. Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 cells. Immunol 27:485-517
35. Numasaki M, Lotze MT, Sasaki H (2004) Interleukin-17 augments tumor necrosis factor-a-induced elaboration of proangio-genic factors from fibroblasts. Immunol Lett 93:39-43 (Pubitemid 38591518)
36. Takahashi H, Numasaki M, Lotze MT, Sasaki H (2005) Inter-leukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells. Immunol Lett 98:189-193 (Pubitemid 40602629)
37. Honorati MC, Neri S, Cattini L, Facchini A (2006) Interleukin-17, a regulator of angiogenic factor release by synovial fibro-blasts. Osteoarthr Cartil 14:345-352
38. Heidenreich R, Röcken M, Ghoreschi K (2009) Angiogenesis drives psoriasis pathogenesis. Int J Exp Path 90:232-248
39. Murugaiyan G, Saha B (2009) Protumor vs antitumor functions of IL-17. J Immunol 183:4169-4175
40. Zhang B, Rong G, Wie H, Zhang M, Bi J, Ma L, Xue X, Wie G, Liu X, Fang G (2008) The prevalence of Th17 cells in patients with gastric cancer. Biochem Biophys Res Commun 374:533-537
41. Numasaki M, Watanabe M, Suzuki T, Takahashi H, Nakamura A, McAllister F, Hishinuma T, Goto J, Lotze MT, Kolls JK, Sasaki H (2005) IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol 175:6177-6189 (Pubitemid 41508106)
42. Tartour E, Fossiez F, Joyeux I, Galinha A, Gey A, Claret E, Sastre-Garau X, Couturier J, Mosseri V, Vives V (1999) Inter-leukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res 59:3698-3704 (Pubitemid 29381875)
43. Wang L, Tangsheng Y, Kortylewski M, Pardoll DM, Zeng D, Yu HJ (2009) IL-17 can promote tumor growth through an IL-6- Stat3 signaling pathway. Exp Med 206(7):1457-1464
44. Langowski JL, Zhang X, Wu L (2006) IL-23 promotes tumour incidence and growth. Nature 442:461-465 (Pubitemid 44264796)
45. Xiao M, Wang C, Zhang J, Zhiguang L, Zhao X, Qin Z (2009) IFNγ promotes papilloma development by up-regulating Th17-associated inflammation. Cancer Res 69:2010-2017
46. Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21:467-476 (Pubitemid 39370503)
47. Zhu X, Mulcahy LA, Mohammed RAA, Lee AHS, Franks HA, Kilpatrick L, Yilmazer A, Paish EC, Ellis IO, Patel PM, Jackson AM (2008) IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines. Breast Cancer Res 10:R95
48. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, Filler SG, Masso-Welch P, Edgerton M, Gaffen SL (2009) Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206(2):299-311
49. Kryczek I, Wei S, Szeliga W, Vatan L, Zou W (2009) Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood 114:357-359